{
    "title": "Organon results beat estimates on demand for women heath products, biosimilars",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12385385/Organon-results-beat-estimates-demand-women-heath-products-biosimilars.html",
    "date": "2023-08-08",
    "keywords": [
        "revenue",
        "company",
        "secondquarter",
        "demand",
        "estimate",
        "health",
        "dobbs",
        "version",
        "treatment",
        "organon",
        "biosimilar",
        "drug",
        "interchangeability",
        "co",
        "tuesday",
        "heath",
        "healthcare",
        "beating",
        "segment",
        "contraceptive",
        "nexplanon",
        "decision",
        "increase",
        "program",
        "channel",
        "conference",
        "call",
        "case",
        "v",
        "jackson",
        "organization",
        "court",
        "june",
        "year",
        "ruling",
        "right",
        "abortion",
        "companys",
        "unit",
        "remicade",
        "partner",
        "samsung",
        "bioepis",
        "july",
        "humira",
        "month",
        "discount",
        "cost",
        "designation",
        "reference",
        "product",
        "indication",
        "trial",
        "summer",
        "dip",
        "forecast",
        "profit",
        "quarter",
        "roy",
        "bengaluru",
        "editing",
        "vinay",
        "dwivedi"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}